Header menu link for other important links
Nanoemulsions: The rising star of antiviral therapeutics and nanodelivery system—current status and prospects
J.S. Franklyne, P.M. Gopinath, ,
Published in Elsevier Ltd
Volume: 54
Nanoemulsions (NEs) of essential oil (EO) have significant potential to target microorganisms, especially viruses. They act as a vehicle for delivering antiviral drugs and vaccines. Narrowing of drug discovery pipeline and the emergence of new viral diseases, especially, coronavirus disease, have created a niche to use NEs for augmenting currently available therapeutic options. Published literature demonstrated that EOs have an inherent broad spectrum of activity across bacterial, fungal, and viral pathogens. The emulsification process significantly improved the efficacy of the active ingredients in the EOs. This article highlights the research findings and patent developments in the last 2 years especially, in EO antiviral activity, antiviral drug delivery, vaccine delivery, viral resistance development, and repurposing EO compounds against SARS-CoV-2. © 2021 Elsevier Ltd
About the journal
JournalData powered by TypesetCurrent Opinion in Colloid and Interface Science
PublisherData powered by TypesetElsevier Ltd